These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 20216063)

  • 1. Use of clotting factors and other prohemostatic drugs for obstetric hemorrhage.
    Mercier FJ; Bonnet MP
    Curr Opin Anaesthesiol; 2010 Jun; 23(3):310-6. PubMed ID: 20216063
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recombinant factor VIIa and other pro-haemostatic therapies in primary postpartum haemorrhage.
    Searle E; Pavord S; Alfirevic Z
    Best Pract Res Clin Obstet Gynaecol; 2008 Dec; 22(6):1075-88. PubMed ID: 18838340
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prohemostatic interventions in obstetric hemorrhage.
    Bonnet MP; Basso O
    Semin Thromb Hemost; 2012 Apr; 38(3):259-64. PubMed ID: 22510859
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Management of massive bleeding in 2013: seven questions and answers].
    Godier A; Samama CM; Susen S
    Transfus Clin Biol; 2013 May; 20(2):55-8. PubMed ID: 23587620
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hemostatic resuscitation in postpartum hemorrhage - a supplement to surgery.
    Ekelund K; Hanke G; Stensballe J; Wikkelsøe A; Albrechtsen CK; Afshari A
    Acta Obstet Gynecol Scand; 2015 Jul; 94(7):680-692. PubMed ID: 25660118
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transfusion therapy in postpartum hemorrhage.
    Padmanabhan A; Schwartz J; Spitalnik SL
    Semin Perinatol; 2009 Apr; 33(2):124-7. PubMed ID: 19324242
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Postpartum hemorrhage in a Jehovah's Witness patient controlled with Tisseel, tranexamic acid, and recombinant factor VIIa.
    Arab TS; Al-Wazzan AB; Maslow K
    J Obstet Gynaecol Can; 2010 Oct; 32(10):984-7. PubMed ID: 21176309
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Postpartum hemorrhage management in 2012: predicting the future.
    Onwuemene O; Green D; Keith L
    Int J Gynaecol Obstet; 2012 Oct; 119(1):3-5. PubMed ID: 22867727
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Transfusion for post-partum haemorrhage: what's new in 2011?].
    Bonnet MP; Tesnière A; Mignon A
    Transfus Clin Biol; 2011 Apr; 18(2):129-32. PubMed ID: 21420343
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Using recombinant activated factor VII, B-Lynch compression, and reversible embolization of the uterine arteries for treatment of severe conservatively intractable postpartum hemorrhage: new method for management of massive hemorrhage in cases of placenta increta.
    Mechsner S; Baessler K; Brunne B; Albrecht T; Hopp H; Dudenhausen JW
    Fertil Steril; 2008 Nov; 90(5):2012.e1-5. PubMed ID: 18462726
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Massive postpartum hemorrhage: recombinant factor VIIa use is safe but not effective.
    Kalina M; Tinkoff G; Fulda G
    Del Med J; 2011 Apr; 83(4):109-13. PubMed ID: 21675158
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Medical management of postpartum hemorrhage: An update.
    Pacheco LD; Saade GR; Hankins GDV
    Semin Perinatol; 2019 Feb; 43(1):22-26. PubMed ID: 30503399
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recombinant factor VIIa in the management of postpartum bleeds: an audit of clinical use.
    Sobieszczyk S; Breborowicz GH; Platicanov V; Tanchev S; Kessler CM
    Acta Obstet Gynecol Scand; 2006; 85(10):1239-47. PubMed ID: 17068684
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of recombinant activated Factor VII in major obstetric haemorrhage: the Farnborough experience.
    Wissa I; Ebeid E; El-Shawarby S; Chandakas S; Kamal T; Hill N
    J Obstet Gynaecol; 2009 Jan; 29(1):21-4. PubMed ID: 19280490
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Massive transfusion and nonsurgical hemostatic agents.
    Perkins JG; Cap AP; Weiss BM; Reid TJ; Bolan CD
    Crit Care Med; 2008 Jul; 36(7 Suppl):S325-39. PubMed ID: 18594260
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of recombinant activated factor VII in obstetric hemorrhage.
    Ahonen J
    Curr Opin Anaesthesiol; 2012 Jun; 25(3):309-14. PubMed ID: 22473215
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Haemostatic management of obstetric haemorrhage.
    Collis RE; Collins PW
    Anaesthesia; 2015 Jan; 70 Suppl 1():78-86, e27-8. PubMed ID: 25440400
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Emerging treatment strategies for trauma-induced coagulopathy.
    Sorensen B; Fries D
    Br J Surg; 2012 Jan; 99 Suppl 1():40-50. PubMed ID: 22441854
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recombinant activated factor VII in obstetric hemorrhage: experiences from the Australian and New Zealand Haemostasis Registry.
    Phillips LE; McLintock C; Pollock W; Gatt S; Popham P; Jankelowitz G; Ogle R; Cameron PA;
    Anesth Analg; 2009 Dec; 109(6):1908-15. PubMed ID: 19923520
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The early use of fibrinogen, prothrombin complex concentrate, and recombinant-activated factor VIIa in massive bleeding.
    Fries D
    Transfusion; 2013 Jan; 53 Suppl 1():91S-95S. PubMed ID: 23301979
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.